Line 56: |
Line 56: |
| | | |
| | | |
− |
| + | An increase in pancreatic digestive enzymes (amylase, lipase, trypsin-like immunoreactivity (TLI), phospholipase A2 and pancreatic lipase immunoreactivity (PLI)) will also be present. |
− | An increase in pancreatic digestive enzymes (amylase, lipase, trypsin-like immunoreactivity (TLI), phospholipase A2 and pancreatic lipase immunoreactivity (PLI)) | |
| | | |
| ===Pancreas-specific laboratory tests=== | | ===Pancreas-specific laboratory tests=== |
Line 76: |
Line 75: |
| '''Abdominal Ultrasound''': Highly specific with a sensitivity of 70% in dogs and 30% in cats but is operator-dependant. Findings include | | '''Abdominal Ultrasound''': Highly specific with a sensitivity of 70% in dogs and 30% in cats but is operator-dependant. Findings include |
| pancreatic enlargement, peritoneal effusion, hypoechogenic pancreas (pancreatic necrosis) and hyperechogenic surrounding tissue. | | pancreatic enlargement, peritoneal effusion, hypoechogenic pancreas (pancreatic necrosis) and hyperechogenic surrounding tissue. |
− | *Chronic pancreatitis and fibrosis may be hyperechogenic
| |
| | | |
| ===Exploratory Laparotomy/Necropsy Findings=== | | ===Exploratory Laparotomy/Necropsy Findings=== |
− | *The pancreas will be oedematous, soft with fibrinous attachments to surrounding organs
| + | The pancreas will be oedematous, soft with fibrinous attachments to surrounding organs, there may be free fluid within the peritoneal cavity and pancreas liquefaction if severe enough. |
− | *Free fluid within the peritoneal cavity
| + | Pseudocysts may be present, as well as omental and pancreatic haemorrhages and areas of fat necrosis. |
− | *Pancreas liquefaction if severe enough
| |
− | *Formation of pseudocysts
| |
− | *Omental and pancreatic haemorrhages
| |
− | *Areas of fat necrosis
| |
| | | |
− | However a biopsy should be taken to provide evidence of inflammation.
| + | A biopsy should be taken to provide evidence of inflammation. |
| | | |
| ==Treatment== | | ==Treatment== |